Theseus Pharmaceuticals Inc. hired Tim Clackson as president and CEO to succeed Iain Dukes, the co-founder and OrbiMed venture partner who has held the CEO role on an interim basis. Dukes will
Connect raises $115M C round, eyes pivotal trialsRA Capital’s Derek DiRocco will join the board of Suzhou Connect Biopharmaceuticals Ltd. after the firm led the Chinese biotech’s